Complizen Learn

AI tools can speed up specific parts of FDA medical device regulatory work, especially first-pass predicate research, guidance discovery, requirements checklists, gap spotting, and first-draft writing. The biggest risk is accuracy: general-purpose LLMs can generate confident text with false facts or hallucinated citations, so you should treat them as drafting and research assistants, not as sources of truth. Specialized regulatory platforms like Complizen reduce verification

A predicate device is a legally marketed U.S. device with the same intended use and technological characteristics that do not raise different questions of safety and effectiveness compared with your device. Find candidates in FDA’s Product Classification Database (by product code), FDA’s 510(k) database (by device name/manufacturer), and AccessGUDID (public UDI)—which often lists premarket submission numbers you can pivot on. Pick well and you streamline review; pick poorly a

Medical device startups have 8 primary funding sources: government grants ($305K-$3M, non-dilutive), angel investors ($50K-$2M, 10-25% equity), venture capital ($1M-$100M+, 15-30% equity per round), crowdfunding ($50K-$1M, variable terms), accelerators ($25K-$250K + mentorship), corporate partnerships, revenue-based financing, and bootstrapping. The smart play is sequencing: validate with grants, bridge with angels, then scale with venture—layering in partnerships or revenue-

FDA maintains 15+ medical device databases containing approval data, adverse events, manufacturer information, and regulatory guidance. The most critical are the 510(k) database for predicate devices, PMA database for Class III research, Product Classification for device codes, and MAUDE for safety intelligence. Smart companies use these databases for competitive intelligence, faster regulatory submissions, and market analysis. Most regulatory professionals waste hours manual

eSTAR is FDA’s interactive PDF template that structures medical-device submissions in the same layout reviewers use, with built-in checks and required sections. It’s mandatory for 510(k) (since Oct 1, 2023) and becomes mandatory for De Novo on Oct 1, 2025. FDA has a draft to use eSTAR for Q-Submissions; when finalized it will set the start date. This guide covers eSTAR compliance deadlines, technical requirements, and submission preparation procedures. What Is FDA's eSTAR Pro

Starting October 1, 2025, all De Novo requests for SaMD must be submitted using the FDA’s eSTAR template. This shift brings new module requirements tailored to software, including design documentation, cybersecurity, verification/validation, and AI lifecycle controls. If you're preparing a SaMD De Novo, this format isn’t optional—it’s the new standard. What Is eSTAR? eSTAR stands for Electronic Submission Template and Resource. It’s a structured, interactive PDF the FDA devel

A 510(k) shows your device is substantially equivalent to a cleared predicate. Use this checklist to build the submission in the order...

In today’s world, artificial intelligence (AI) plays a key role in making complex tasks easier and faster. For those in the medical...